Skip to main content
HIT
NASDAQ Finance

Health In Tech Swings to Q2 Loss, Reaffirms $45-50M Revenue Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Negative
Importance info
7
Price
$1.021
Mkt Cap
$69.467M
52W Low
$0.85
52W High
$4.02
52W Position info
20% above low
Off High info
75% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

HIT sits 20% above its 52-week low of $0.85.

Summary

Health In Tech posted a Q2 2026 net loss of $2.5 million on revenue of $8.1 million, down from a profit of $0.6 million a year ago. Full-year revenue guidance of $45-50 million was reaffirmed.


Key Events · Earnings and Guidance · HIT

  • Q2 Loss vs Prior-Year Profit

    Net loss of $2.5 million, or $(0.04) per diluted share, compared to net income of $0.6 million, or $0.01 per share, in Q2 2025.

  • Revenue Declines 13%

    Q2 2026 revenue was $8.1 million, down from $9.3 million in Q2 2025, driven by a 39% drop in underwriting modeling revenue.

  • Operating Cash Burn

    Operating activities used $2.9 million in cash during Q2 2026, leaving $6.5 million in cash and equivalents as of June 30, 2026.

  • Guidance Reaffirmed

    Full-year 2026 revenue guidance of $45 million to $50 million was reaffirmed, supported by $32.3 million in contracted revenue and a $66.3 million pipeline.


Analysis · HIT · Finance

The quarter's swing to a $2.5 million net loss from a $0.6 million profit a year earlier reflects a 13% revenue decline and a 32% jump in operating expenses. Operating cash burn reached $2.9 million, leaving $6.5 million in cash. Management reaffirmed full-year revenue guidance of $45-50 million, backed by $32.3 million in contracted revenue and a $66.3 million pipeline, but the near-term profitability deterioration and cash burn dominate the story.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HIT was trading at $1.02 on NASDAQ in the Finance sector, with a market capitalization of approximately $69.5M. The 52-week trading range was $0.85 to $4.02. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HIT - Latest Insights

HIT
Nov 13, 2026, 5:17 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.4017
Real-time Price: $0.3298 info
Change: -$0.0719 (-18%) info
Market Cap: $21.536M info
HIT
Nov 13, 2026, 5:08 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4017
Real-time Price: $0.3298 info
Change: -$0.0719 (-18%) info
Market Cap: $21.536M info
HIT
Nov 12, 2026, 4:30 PM EST
Source: PR Newswire
Importance Score:
8
Price at Filing: $0.540
Real-time Price: $0.3298 info
Change: -$0.2102 (-39%) info
Market Cap: $21.536M info
HIT
Nov 12, 2026, 8:09 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.550
Real-time Price: $0.3298 info
Change: -$0.2202 (-40%) info
Market Cap: $21.536M info
HIT
Nov 06, 2026, 4:34 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.5574
Real-time Price: $0.3298 info
Change: -$0.2276 (-41%) info
Market Cap: $21.536M info